Weight Loss

Tirzepatide

Dual GIP/GLP-1 receptor agonist widely used in metabolic research.

Select Strength

$155

Final price — no added fees

Overview

Tirzepatide is a dual-incretin research peptide acting on both GIP and GLP-1 receptors. Offered in 30MG and 60MG vials for extended study protocols.

Research Background

Research literature explores dual incretin agonism for its influence on satiety signaling, insulin sensitivity, and body-weight endpoints relative to single-pathway agonists.

Specifications

Purity: ≥ 99% (HPLC verified)
Form: Lyophilized powder, sealed vial
Storage: Store at 2–8°C. Protect from light. Reconstituted: refrigerate and use within 30 days.
Strength: 30MG

Research use only. Not intended for human or animal consumption. Must be 18+.